SAN DIEGO -- Patients with mantle cell lymphoma (MCL) and undetectable minimal residual disease (uMRD) after induction ...
4d
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...
The "sledgehammer-like treatment" of stem cell transplants had no benefit for most mantle cell lymphoma patients, according ...
Trial reveals no survival benefit from autologous stem cell transplant for mantle cell lymphoma patients with undetectable ...
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...
Autologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first ...
Autologous stem cell transplant plus Rituxan did not improve survival outcomes in certain patients with mantle cell lymphoma compared with Rituxan alone.
Autologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in f ...
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant (ASCT) for patients with mantle cell lymphoma (MCL) in remission following ...
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...
The 66th American Society of Hematology Annual Meeting & Exposition will take place December 7-10, 2024, in San Diego, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback